Physician profile
Derrick C Pau
NPI 1447404447
$3,111.27
in general payments reported to CMS, 2019-2025
23 companies · $656 in 2025
The $656 reported for 2025 was more than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $446 · 2021: $371 · 2022: $309 · 2023: $346 · 2024: $295 · 2025: $656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,296.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $539.34 | 2019-2021 | |
| Alcon Vision LLC | $519.75 | 2020-2025 | Rocklatan, Voyager Dslt, Hydrus Microstent |
| Abbvie INC. | $335.85 | 2022-2025 | |
| Sight Sciences, INC. | $299.87 | 2019-2023 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $291.65 | 2023-2025 | Vyzulta, Prolensa, Lotemax Sm |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $203.74 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $156.82 | 2021-2022 | |
| Glaukos Corporation | $96.62 | 2023-2024 | Idose |
| Johnson & Johnson Surgical Vision, INC. | $96.02 | 2023-2025 | Tecnis Simplicity, Veritas Vision System, Tecnis Iol |
| Aerie Pharmaceuticals, INC. | $90.20 | 2019-2021 | |
| Akorn, INC. | $88.84 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $85.80 | 2021-2023 | Acthar |
| Kala Pharmaceuticals, INC. | $57.42 | 2019-2020 | |
| Amgen INC. | $44.98 | 2024-2025 | Tepezza |
| Novartis Pharmaceuticals Corporation | $36.93 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $30.91 | 2025 | Ahmed Glaucoma Valve, Streamline, Clearpath |
| Harrow Eye, LLC | $28.33 | 2024 | Iheezo |
| Mallinckrodt Enterprises LLC | $23.51 | 2019 | |
| Rxsight INC | $22.22 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Ivantis, INC | $20.53 | 2021 | |
| Akorn Operating Company LLC | $17.43 | 2021 | |
| Medline Industries LP | $15.84 | 2021 | |
| Iridex Corporation | $8.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derrick Pau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.